Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

98 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Trebananib (AMG 386) plus weekly paclitaxel with or without bevacizumab as first-line therapy for HER2-negative locally recurrent or metastatic breast cancer: A phase 2 randomized study.
Diéras V, Wildiers H, Jassem J, Dirix LY, Guastalla JP, Bono P, Hurvitz SA, Gonçalves A, Romieu G, Limentani SA, Jerusalem G, Lakshmaiah KC, Roché H, Sánchez-Rovira P, Pienkowski T, Seguí Palmer MÁ, Li A, Sun YN, Pickett CA, Slamon DJ. Diéras V, et al. Among authors: lakshmaiah kc. Breast. 2015 Jun;24(3):182-90. doi: 10.1016/j.breast.2014.11.003. Epub 2015 Mar 5. Breast. 2015. PMID: 25747197 Clinical Trial.
Fixed dose combination of capecitabine and cyclophosphamide in metastatic breast cancer: Results from THE ENCLOSE phase 2/3 randomized multicenter study.
Gupta S, Biswas G, Babu S, Maksud TM, Lakshmaiah KC, Patel JG, Raja G, Boya RR, Patil P, Choudhury K, Bondarde SA, Neve RS, Bhat G, Mamillapalli G, Patel AA, Patel P, Joshi N, Bajaj V, Khan MA. Gupta S, et al. Among authors: lakshmaiah kc. Breast. 2021 Dec;60:147-154. doi: 10.1016/j.breast.2021.09.012. Epub 2021 Oct 1. Breast. 2021. PMID: 34624757 Free PMC article. Clinical Trial.
A Real-World Study of Safety, Immunogenicity and Efficacy of Bevacizumab in Patients With Solid Malignancies: A Phase IV, Post-Marketing Study in India.
Sinha SD, Biswas G, Bheemareddy BR, Chary S, Thakur P, Jain M, Maksud T, Pawar S, Chatterjee K, Voonna MK, Goel A, Puligundla KC, Lakshmaiah KC, Talluri L, Vattipalli R, Kakkunnath S. Sinha SD, et al. Among authors: lakshmaiah kc. Cancer Inform. 2023 Jun 1;22:11769351231177277. doi: 10.1177/11769351231177277. eCollection 2023. Cancer Inform. 2023. PMID: 37313371 Free PMC article.
Rituximab biosimilar for the treatment of diffuse large B-cell lymphoma: a phase 3 randomized study in India.
Patel A, Bhatt N, Prakash SS, Biswas G, Nagarkar R, Roy B, Samal P, Agrawal N, Meshram S, Kaushal A, Satheesh CT, Wategaonkar R, Thiagarajan KV, Jain K, Vijayaveeran P, Mukherjee K, Singh K, Patil T, Jain A, Dolai TK, Jain M, Hingmire S, Gupta TC, Lakshmaiah KC, Rajamanickam D, Nemade B, Goyal V, Mahato P, Mendiratta SK, Doshi M. Patel A, et al. Among authors: lakshmaiah kc. Cancer Chemother Pharmacol. 2023 Jun;91(6):457-468. doi: 10.1007/s00280-023-04530-x. Epub 2023 Apr 24. Cancer Chemother Pharmacol. 2023. PMID: 37093266 Free PMC article. Clinical Trial.
Clinical profile, cytogenetics and treatment outcomes of adult acute myeloid leukemia.
Namratha Udupa MS, Babu KG, Suresh Babu MC, Lakshmaiah KC, Lokanatha D, Jacob AL, Lokesh KN, Rajeev LK, Rudresh AH, Devi L. Namratha Udupa MS, et al. Among authors: lakshmaiah kc. J Cancer Res Ther. 2020 Jan-Mar;16(1):18-22. doi: 10.4103/jcrt.JCRT_1162_16. J Cancer Res Ther. 2020. PMID: 32362604 Free article.
Every distant deposit is not a metastasis: Synchronous primaries do exist.
Babu G, Asati V, Lakshmaiah KC, Lokanatha D, Jacob LA, Babu S, Lokesh KN, Rudresh AH, Rajeev LK, Saldanha S, Chethan R, Koppaka D, Premalata CS. Babu G, et al. Among authors: lakshmaiah kc. Indian J Cancer. 2019 Jan-Mar;56(1):70-73. doi: 10.4103/ijc.IJC_637_17. Indian J Cancer. 2019. PMID: 30950449 Free article.
A prospective study to compare the measured glomerular filtration rate compared to estimated glomerular filtration rate in patients undergoing definitive chemoradiation, with platinum agents for various malignancies.
Rudresh AH, Asati V, Lakshmaiah KC, Lokanatha D, Babu S, Rajeev LK, Lokesh KN, Babu G. Rudresh AH, et al. Among authors: lakshmaiah kc. J Cancer Res Ther. 2019 Mar;15(Supplement):S56-S59. doi: 10.4103/0973-1482.204881. J Cancer Res Ther. 2019. PMID: 30900622 Free article.
98 results